EUVIMEDDescoperă EUVIMED
Leserbrief

Letter: Methodological Considerations in Interpreting Polygenic Risk Scores for Hepatocellular Carcinoma After SVR

Zhejin Shi, Haoyi Li, Zichen Yu iD

Alimentary Pharmacology & Therapeutics · 2026-05 · 63 (10) · 1437-1438

DOI: 10.1111/apt.70595 ↗

At a glance

Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-03-07. Written by Zhejin Shi and 2 co-authors. Institution: The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. Cited 1 times so far (Crossref); 10 references.

RezumatDate bibliograficeCiteRelated studies

Abstract (original language)

Niciun rezumat disponibil.

Authors and institutions

  • The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Department of Postgraduate Training, Base Alliance of Wenzhou Medical University, Wenzhou, Zhejiang, China.

ORCID profiles: Zichen Yu

Cite

APA

Shi, Z., Li, H., & Yu, Z. (2026). Letter: Methodological Considerations in Interpreting Polygenic Risk Scores for Hepatocellular Carcinoma After SVR. Alimentary Pharmacology & Therapeutics, 63(10), 1437-1438. https://doi.org/10.1111/apt.70595

Vancouver

Shi Z, Li H, Yu Z. Letter: Methodological Considerations in Interpreting Polygenic Risk Scores for Hepatocellular Carcinoma After SVR. Alimentary Pharmacology & Therapeutics. 2026;63(10):1437-1438. doi:10.1111/apt.70595

BibTeX
@article{Shi2026,
  author = {Shi, Zhejin and Li, Haoyi and Yu, Zichen},
  title = {Letter: Methodological Considerations in Interpreting Polygenic Risk Scores for Hepatocellular Carcinoma After SVR},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {63},
  number = {10},
  pages = {1437--1438},
  doi = {10.1111/apt.70595}
}
Start for free →